Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy?
- 1 March 2009
- journal article
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 28 (3), 231-236
- https://doi.org/10.1016/j.healun.2008.12.015
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Discordance Between Patient-Predicted and Model-Predicted Life Expectancy Among Ambulatory Patients With Heart FailureJAMA, 2008
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationNew England Journal of Medicine, 2007
- Validation of the Seattle Heart Failure Model in a Community-Based Heart Failure Population and Enhancement by Adding B-Type Natriuretic PeptideThe American Journal of Cardiology, 2007
- Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart FailureCirculation, 2007
- Candidate Selection for Long-term Left Ventricular Assist Device Therapy for Refractory Heart FailureThe Journal of Heart and Lung Transplantation, 2006
- The Seattle Heart Failure ModelCirculation, 2006
- ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the AdultJournal of the American College of Cardiology, 2005
- Peak Oxygen Consumption as a Predictor of Death in Patients With Heart Failure Receiving β-BlockersCirculation, 2005
- A prognostic model for predicting waiting-list mortality for a total national cohort of adult heart-transplant candidatesTransplantation, 2003
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001